We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

172 hedge funds and large institutions have $1.73B invested in NxStage Medical Inc. in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more funds holding in top 10

Funds holding in top 10: 6 → 11 (+5)

7% more capital invested

Capital invested by funds: $1.61B → $1.73B (+$119M)

2% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 58

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

2% less funds holding

Funds holding: 175 → 172 (-3)

59% less call options, than puts

Call options by funds: $1.18M | Put options by funds: $2.86M

Holders
172
Holders Change
-3
Holders Change %
-1.71%
% of All Funds
3.83%
Holding in Top 10
11
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+83.33%
% of All Funds
0.25%
New
22
Increased
57
Reduced
58
Closed
24
Calls
$1.18M
Puts
$2.86M
Net Calls
-$1.68M
Net Calls Change
-$574K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$46.5M
2
WCMNY
Westchester Capital Management (New York)
New York
+$31.3M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$23.1M
4
MP
Manikay Partners
New York
+$19.9M
5
KLCMU
Kite Lake Capital Management (UK)
United Kingdom
+$18.6M

Top Sellers

Rank Fund Capital Flow
1
WIC
Water Island Capital
New York
-$25.9M
2
AAM
Alpine Associates Management
Florida
-$16.8M
3
MCP
Moab Capital Partners
New York
-$15.1M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$14.1M
5
Flossbach Von Storch
Flossbach Von Storch
Germany
-$10.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
HSBC Holdings
76
HSBC Holdings
United Kingdom
$2.57M +$2.55M +89,923 New
Capstone Investment Advisors
77
Capstone Investment Advisors
New York
$2.49M -$1.96M -69,072 -44%
BPGAM
78
BTG Pactual Global Asset Management
Bermuda
$2.38M +$2.36M +82,969 New
CS
79
Credit Suisse
Switzerland
$2.35M -$3.15M -110,792 -57%
California Public Employees Retirement System
80
California Public Employees Retirement System
California
$2.35M -$216K -7,606 -8%
HM
81
Harvest Management
New York
$2.32M +$1.87M +66,000 +440%
PCM
82
Prelude Capital Management
New York
$2.23M +$1.02M +36,012 +86%
PI
83
PEAK6 Investments
Illinois
$2.03M +$645K +22,700 +47%
AQR Capital Management
84
AQR Capital Management
Connecticut
$1.87M +$85K +2,992 +5%
New York State Common Retirement Fund
85
New York State Common Retirement Fund
New York
$1.82M -$301K -10,600 -14%
SMC
86
S. Muoio & Co
New York
$1.72M +$1.42M +50,000 +490%
OTPPB
87
Ontario Teachers' Pension Plan Board
Ontario, Canada
$1.72M – – –
Bank of America
88
Bank of America
North Carolina
$1.67M +$1.09M +38,315 +191%
Invesco
89
Invesco
Georgia
$1.53M +$787K +27,702 +108%
YCM
90
Yakira Capital Management
Connecticut
$1.51M -$256K -9,000 -15%
UBS AM
91
UBS AM
Illinois
$1.49M +$241K +8,483 +20%
Barclays
92
Barclays
United Kingdom
$1.35M -$1.84M -64,909 -58%
State Board of Administration of Florida Retirement System
93
State Board of Administration of Florida Retirement System
Florida
$1.31M – – –
AIG
94
American International Group
New York
$1.24M +$11.2K +393 +0.9%
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.14M -$56.5K -1,990 -5%
EAM
96
Exane Asset Management
France
$1.1M -$5.06K -178 -0.5%
BCM
97
Beryl Capital Management
California
$1.09M +$127K +4,476 +13%
DCM
98
Dupont Capital Management
Delaware
$1.02M -$509K -17,900 -33%
PAM
99
Panagora Asset Management
Massachusetts
$913K +$314K +11,058 +53%
PG
100
Pendal Group
Australia
$901K +$894K +31,470 New
2 3
4
5 6

NXTM Hedge Fund Activity: Q4 2018 in Review

172 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2018, worth a combined $1.73B — up 7.4% from $1.61B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of NXTM and 22 opened new positions — a net loss of 2 holders — while 58 trimmed existing stakes and 57 added.

The largest buyer was Citadel Advisors, adding an estimated $46.5M. The largest seller was Water Island Capital, cutting an estimated $25.9M.

  • 172 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2018, down from 175 in Q3 2018.
  • Funds reported $1.73B of NxStage Medical Inc. stock for Q4 2018, up 7.4% quarter-over-quarter.
  • 22 funds opened new NxStage Medical Inc. positions in Q4 2018 and 24 closed out, a net change of -2 holders.
  • The largest NxStage Medical Inc. buyer in Q4 2018 was Citadel Advisors, an estimated $46.5M added.
  • The largest NxStage Medical Inc. seller in Q4 2018 was Water Island Capital, an estimated $25.9M sold.

Based on aggregated 13F filings for Q4 2018.